Acquiring Company
AbbVie Inc.
Acquired Company
AbbVie Inc.
North ChicagoNorth ChicagoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaDescription
AbbVie Inc. has agreed to acquire Cerevel Therapeutics Holdings, Inc. for $45 per share, nearly double the price from Cerevel's recent stock offering. This acquisition is expected to enhance AbbVie's portfolio in the neuroscience sector. Bain Capital and Pfizer, Cerevel's controlling shareholders, benefited significantly from this transaction. Investors in Cerevel may seek compensation concerning the acquisition details.
Quick answer
AbbVie Inc. is acquiring AbbVie Inc., announced May 28, 2025. AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who acquired AbbVie Inc?
- AbbVie Inc. agreed to acquire AbbVie Inc. on May 28, 2025.
- How much did AbbVie Inc. pay for AbbVie Inc?
- The deal value was not disclosed.
- Where are AbbVie Inc. and AbbVie Inc. based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- AbbVie to acquire Capstan Therapeutics for $2.1B, $2.1B (June 30, 2025)
- BioMarin completes acquisition of Inozyme Pharma (July 1, 2025)
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- Exicure, Inc. acquires GPCR USA for cancer therapy expansion (June 27, 2025)
- Rubicon Research acquires Alkem's manufacturing unit (June 24, 2025)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired AbbVie Inc.?
AbbVie Inc. was acquired by AbbVie Inc., based in North Chicago. The deal was reported on May 28, 2025. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire AbbVie Inc.?
AbbVie Inc.'s acquisition of AbbVie Inc. was reported on May 28, 2025. AbbVie Inc. has agreed to acquire Cerevel Therapeutics Holdings, Inc. for $45 per share, nearly double the price from Cerevel's recent stock offering. This acquisition is expected to enhance AbbVie's portfolio in the neuroscience sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AbbVie Inc. do?
Venture capital subsidiary of Abbvie It is publicly traded (ABBV), operating in Manufacturing, and is based in North Chicago.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.